Otsuka Holdings Co., Ltd.｜Home Page

Otsuka-people creating new products for better health worldwide

Otsuka Holdings Co.,Ltd.

19 Jun 2013

Otsuka Holdings Announces Completion of Share Repurchase (105KB)

14 Jun 2013

A New Choice of Therapy for the Treatment of Depression:
ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatment of Depression in Japan (109KB)

4 Jun 2013

Notice regarding Status of Acquisition of Own Shares (96KB)

22 May 2013

Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter into an exclusive distribution agreement of HES products, including the newly approved Voluven 6% (127KB)

16 May 2013

Notice of the Result of Share Repurchase through ToSTNeT-3 (104KB)

News Archive

Otsuka Pharmaceutical Co.,Ltd.

14 Jun 2013

A New Choice of Therapy for the Treatment of Depression:
ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatment of Depression in Japan

10 Jun 2013

The No.1 pharmacist-recommended supplement*1「Nature Made」
The First Supplement Facility was Built in Alabama*2.
Production Capacity Increases 40% by 2014

7 Jun 2013

Otsuka has been selected by METI as a model enterprise for business continuity management

3 Jun 2013

Otsuka Pharmaceutical Submits New Drug Application in Japan for Tolvaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

3 Jun 2013

Vasopressin V2 Receptor Antagonist Samsca® 7.5mg Tablets To Be Launched in Japan on June 4 – Additional Choice of Dose for the Treatment of Volume Overload in Patients with Heart Failure

News Archive

Otsuka Pharmaceutical Factory,Inc.

22 May 2013

Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter into an exclusive distribution agreement of HES products, including the newly approved Voluven 6% (127KB)

7 Dec 2012

Otsuka Pharmaceutical Factory and Mitsui enter into IV solutions business in India (290KB)

14 Dec 2011

Otsuka Techno to Construct New Factory at Industrial Park in Naruto, Tokushima (267KB)

28 Nov 2011

J.O. Pharma Co., Ltd. to construct a new manufacturing facility for
prefilled syringes (a syringe with injectable drug solution filled in advance): Signing of an agreement with Shimane Prefecture and Izumo City
for the facility construction (264KB)

19 Oct 2011

Otsuka Pharmaceutical Factory and Living Cell Technologies Limited Agree to Establish Joint Venture to Develop and Commercialize Pancreatic Islets as a Treatment for Diabetes (217KB)

News Archive

Taiho Pharmaceutical Co.,Ltd.

6 Jun 2013

Results of Phase III Trials of TS-1 on Patients with Colorectal Cancer and Head and Neck Cancers Announced at ASCO®

24 May 2013

New Plant Constructed in Tokushima Prefecture to Serve as Production Center for Anti-cancer Drugs

3 Apr 2013

Results of the Phase III Clinical Study (GEST) of TS-1 in Patients with Advanced Pancreatic Cancer Published in the Online Version of the Journal of Clinical Oncology

27 Feb 2013

Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102

21 Feb 2013

Antitumor Agent “ABRAXANE(R) I.V. Infusion 100 mg” Approved for Additional Indications of Gastric Cancer and Non-small Cell Lung Cancer

News Archive

Otsuka Chemical Co., Ltd.

12 Dec 2011

Otsuka Chemical Announces Personnel Changes (297KB)

10 Jun 2011

Otsuka Chemical Announces Personnel Changes (112KB)

12 Nov 2009

Otsuka Foods and Otsuka Beverage to merge (102KB)

News Archive

14 May 2013

Otsuka Holdings announces FY2012 financial results.

21 Mar 2013

Otsuka Holdings held R&D Meeting.

13 Mar 2011

Donation of Goods to Disaster Victims of the Tohoku Earthquake (81KB)

Message from the President